Xarelto 20 Mg Tablet - Rivaroxaban
Xarelto 20 Mg Tablet - Rivaroxaban
Xarelto 20 Mg Tablet, containing the active ingredient Rivaroxaban, is a novel oral anticoagulant (NOAC) designed to prevent the formation of harmful blood clots. It is primarily used for conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AFib). This medication is essential for patients with irregular heart rhythms to prevent clot formation and reduce the risk of stroke and heart attack.
Key Features- Prevents and treats blood clots in veins, lungs, brain, and heart.
- Reduces the risk of stroke and heart attack.
- Used in patients with atrial fibrillation and post-surgery for knee or hip replacement.
- Active Ingredient Rivaroxaban
- Strength 20 mg
- Form Film-coated tablet
- Route of Administration Oral
Ideal for patients requiring anticoagulation therapy to prevent clot-related conditions. Suitable for long-term use under medical supervision.
Typical User/Industry ProfilePatients with atrial fibrillation, those undergoing knee or hip replacement surgeries, and individuals at risk of thromboembolic events.
About the BrandXarelto is manufactured by Bayer Pharmaceuticals, a leader in the pharmaceutical industry known for its innovative solutions in healthcare. Bayer has pioneered the development of anticoagulant therapies, making Xarelto a trusted choice for healthcare professionals worldwide.
Original: $57.16
-65%$57.16
$20.01Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Xarelto 20 Mg Tablet - Rivaroxaban
Xarelto 20 Mg Tablet, containing the active ingredient Rivaroxaban, is a novel oral anticoagulant (NOAC) designed to prevent the formation of harmful blood clots. It is primarily used for conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AFib). This medication is essential for patients with irregular heart rhythms to prevent clot formation and reduce the risk of stroke and heart attack.
Key Features- Prevents and treats blood clots in veins, lungs, brain, and heart.
- Reduces the risk of stroke and heart attack.
- Used in patients with atrial fibrillation and post-surgery for knee or hip replacement.
- Active Ingredient Rivaroxaban
- Strength 20 mg
- Form Film-coated tablet
- Route of Administration Oral
Ideal for patients requiring anticoagulation therapy to prevent clot-related conditions. Suitable for long-term use under medical supervision.
Typical User/Industry ProfilePatients with atrial fibrillation, those undergoing knee or hip replacement surgeries, and individuals at risk of thromboembolic events.
About the BrandXarelto is manufactured by Bayer Pharmaceuticals, a leader in the pharmaceutical industry known for its innovative solutions in healthcare. Bayer has pioneered the development of anticoagulant therapies, making Xarelto a trusted choice for healthcare professionals worldwide.
